Literature DB >> 35527420

[A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants].

Chan Liu1, Yu He1, Qing Ai1, Yuan Shi1.   

Abstract

OBJECTIVES: To study the significance of interleukin-6 (IL-6) and interleukin-27 (IL-27) in the differential diagnosis of acute respiratory distress syndrome (ARDS) and neonatal respiratory distress syndrome (NRDS) in preterm infants.
METHODS: The preterm infants with the manifestation of respiratory distress who were treated in the Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, from March to November 2021, were enrolled in this prospective study. According to the diagnosis results, they were divided into two groups: ARDS group (n=18) and NRDS group (n=20). ELISA was used to measure the plasma levels of IL-6 and IL-27. The receiver operating characteristic (ROC) curve was used to analyze the value of each index in the diagnosis of ARDS.
RESULTS: The ARDS group had significantly higher plasma levels of IL-6 and IL-27 than the NRDS group (P<0.05). The ROC curve analysis showed that IL-6 had an area under the ROC curve (AUC) of 0.867 for the diagnosis of ARDS, with a sensitivity of 61.1% and a specificity of 95.0% at the cut-off value of 56.21 pg/mL. The ROC curve analysis also showed that IL-27 had an AUC of 0.881 for the diagnosis of ARDS, with a sensitivity of 83.3% and a specificity of 80.0% at the cut-off value of 135.8 pg/mL.
CONCLUSIONS: Plasma IL-6 and IL-27 can be used as biological indicators for early differential diagnosis of ARDS and NRDS in preterm infants.

Entities:  

Keywords:  Interleukin-27; Interleukin-6; Preterm infant; Respiratory distress syndrome

Mesh:

Substances:

Year:  2022        PMID: 35527420      PMCID: PMC9044985          DOI: 10.7499/j.issn.1008-8830.2111184

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  14 in total

1.  WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.

Authors:  Stefan Pflanz; Linda Hibbert; Jeanine Mattson; Rency Rosales; Elena Vaisberg; J Fernando Bazan; Joseph H Phillips; Terrill K McClanahan; Rene de Waal Malefyt; Robert A Kastelein
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  [Interpretation of Montreux definition of neonatal acute respiratory distress syndrome in 2017].

Authors:  J Y Guo; L Chen; Y Shi
Journal:  Zhonghua Er Ke Za Zhi       Date:  2018-08-02

3.  The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study.

Authors:  Argirios Tsantes; Iraklis Tsangaris; Petros Kopterides; Violetta Kapsimali; Georgios Antonakos; Aikaterini Zerva; Eleni Kalamara; Stefanos Bonovas; George Tsaknis; Eleni Vrigou; Nikolaos Maniatis; Kleanthi Dima; Apostolos Armaganidis
Journal:  Clin Chem Lab Med       Date:  2013-07       Impact factor: 3.694

4.  [Value of IL-6 and IL-8 in the diagnosis of neonatal sepsis].

Authors:  Feng-Xia Zhao; Guang-Hui Liu; Jian Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2015-12

5.  The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity.

Authors:  Daniele De Luca; Anton H van Kaam; David G Tingay; Sherry E Courtney; Olivier Danhaive; Virgilio P Carnielli; Luc J Zimmermann; Martin C J Kneyber; Pierre Tissieres; Joe Brierley; Giorgio Conti; Jane J Pillow; Peter C Rimensberger
Journal:  Lancet Respir Med       Date:  2017-07-04       Impact factor: 30.700

6.  Effect of severe neonatal morbidities on long term outcome in extremely low birthweight infants.

Authors:  Kyo Yeon Koo; Jeong Eun Kim; Soon Min Lee; Ran Namgung; Min Soo Park; Kook In Park; Chul Lee
Journal:  Korean J Pediatr       Date:  2010-06-23

7.  Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27.

Authors:  Stefan Wirtz; Ingrid Tubbe; Peter R Galle; Hans J Schild; Mark Birkenbach; Richard S Blumberg; Markus F Neurath
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

8.  Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Mark Hall; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Michael T Bigham; Anita Sen; Jeffrey Nowak; Michael Quasney; Jared W Henricksen; Arun Chopra; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Thomas P Shanley
Journal:  Crit Care       Date:  2012-10-29       Impact factor: 9.097

9.  IL-27 is elevated in acute lung injury and mediates inflammation.

Authors:  Fang Xu; Qiong Liu; Shihui Lin; Na Shen; Yibing Yin; Ju Cao
Journal:  J Clin Immunol       Date:  2013-07-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.